4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0000899243-19-024432
CIK 0001404281other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 9:30 PM ET
Size
5.6 KB
Accession
0000899243-19-024432
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-09-26+75,000→ 75,000 totalExercise: $0.67Exp: 2029-09-26→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 9:30 PM ET
- Size
- 5.6 KB